Application 205566

Type
ANDA
Sponsor
GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL67MGNoNo
002FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL134MGNoNo
003FENOFIBRATE (MICRONIZED)FENOFIBRATECAPSULE;ORAL200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-6120fenofibratefenofibrateA-S Medication SolutionsANDACurrent
60687-713FenofibrateFenofibrateAmerican Health PackagingANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-580fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-581fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-582fenofibratefenofibrateGlenmark Pharmaceuticals Inc., USAANDACurrent